DMAC

NASDAQ · Biotechnology

Diamedica Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.18

+0.13 (+2.15%)

As of May 9, 1:50 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target -32.7% upside

Low Target $2.49

Average Target $4.16

High Target $4.48

Current Price $6.18

Current
$6.18

Target
$4.16

$2.49 $4.16 avg $4.48

Scenario Analysis

Bear Case

$2.49

-59.7%

Low target

Base Case

$4.16

-32.7%

Avg target

Bull Case

$4.48

+-27.5%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$10.42

-40.7% from high

52-Week Low

$3.48

+77.8% from low

Target vs 52W High

$4.16

-60.1% vs high

Next Earnings Report

May 11, 2026 · After Market Close

Today

EPS Est: $-0.19

Earnings in today. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%